Literature DB >> 17141216

Gossypol inhibits calcineurin phosphatase activity at multiple sites.

Nicholas J Carruthers1, Michael K Dowd, Paul M Stemmer.   

Abstract

Calcineurin, the Ca2+/calmodulin-dependant serine/threonine phosphatase is the target for the immunosuppressant drugs FK506 and cyclosporine-A. These established calcineurin inhibitors each require an immunophilin protein cofactor. Gossypol, a polyphenol produced by the cotton plant, inhibits calcineurin (IC50=15 microM), in a noncompetitive, reversible manner, and is independent of any cofactor. We found that gossypol acts by at least two mechanisms to inhibit calcineurin phosphatase activity. A calmodulin-independent form of calcineurin was less sensitive to inhibition by gossypol than native calcineurin (IC50=41 and 18 microM, respectively) indicating that gossypol may interfere with calmodulin binding. A fluorescence polarization based assay demonstrated that 100 microM gossypol reduced the affinity of calmodulin for calcineurin (from K(d)=2.4 to 250 nM). Inhibition of calcineurin phosphatase activity by gossypol could not be overcome by adding excess calmodulin or by testing the inhibition toward a calmodulin-independent calcineurin indicating that gossypol acts at a site different from the calmodulin-binding site. Gossypol decreased the affinity of calcineurin for immunosuppressant/immunophilin complexes only in the presence of calmodulin, indicating that gossypol blocks the effects of calmodulin binding to calcineurin. In addition, gossypol had a stimulatory effect on native calcineurin in the absence of calmodulin, possibly indicating a calmodulin mimetic effect. Gossypol exists in two enantiomeric forms which are reported to have different potency for cell toxicity. (+) and (-) gossypol had equivalent potency for inhibition of native and calmodulin-independent calcineurin phosphatase activity, and for inhibition of calmodulin binding. The inhibition of calcineurin by gossypol via multiple binding sites without stereo-specificity indicates that gossypol is not a specific calcineurin inhibitor.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17141216     DOI: 10.1016/j.ejphar.2006.10.046

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  8 in total

1.  Methionine oxidation in the calmodulin-binding domain of calcineurin disrupts calmodulin binding and calcineurin activation.

Authors:  Nicholas J Carruthers; Paul M Stemmer
Journal:  Biochemistry       Date:  2008-02-15       Impact factor: 3.162

2.  Gossypol increases expression of the pro-apoptotic BH3-only protein NOXA through a novel mechanism involving phospholipase A2, cytoplasmic calcium, and endoplasmic reticulum stress.

Authors:  Ryan S Soderquist; Alexey V Danilov; Alan Eastman
Journal:  J Biol Chem       Date:  2014-04-28       Impact factor: 5.157

3.  The Dictyostelium prestalk inducer differentiation-inducing factor-1 (DIF-1) triggers unexpectedly complex global phosphorylation changes.

Authors:  Chris Sugden; Michael D Urbaniak; Tsuyoshi Araki; Jeffrey G Williams
Journal:  Mol Biol Cell       Date:  2014-12-17       Impact factor: 4.138

4.  Inhibition of nuclear factor of activated T cells (NFAT) c3 activation attenuates acute lung injury and pulmonary edema in murine models of sepsis.

Authors:  Manjula Karpurapu; Yong Gyu Lee; Ziqing Qian; Jin Wen; Megan N Ballinger; Luiza Rusu; Sangwoon Chung; Jing Deng; Feng Qian; Brenda F Reader; Teja Srinivas Nirujogi; Gye Young Park; Dehua Pei; John W Christman
Journal:  Oncotarget       Date:  2018-01-25

5.  Novel inhibitors of the calcineurin/NFATc hub - alternatives to CsA and FK506?

Authors:  Matthias Sieber; Ria Baumgrass
Journal:  Cell Commun Signal       Date:  2009-10-27       Impact factor: 5.712

6.  Development of a High-throughput NanoBRET Screening Platform to Identify Modulators of the RAS/RAF Interaction.

Authors:  David E Durrant; Emily A Smith; Ekaterina I Goncharova; Nirmala Sharma; Patrick A Alexander; Andrew G Stephen; Curtis J Henrich; Deborah K Morrison
Journal:  Mol Cancer Ther       Date:  2021-06-22       Impact factor: 6.009

7.  Cryptosporidium Lactate Dehydrogenase Is Associated with the Parasitophorous Vacuole Membrane and Is a Potential Target for Developing Therapeutics.

Authors:  Haili Zhang; Fengguang Guo; Guan Zhu
Journal:  PLoS Pathog       Date:  2015-11-12       Impact factor: 6.823

8.  Isolation and characterization of a novel gossypol-degrading bacteria Bacillus subtilis strain Rumen Bacillus Subtilis.

Authors:  Yunhua Zhang; Zhengyou Zhang; Li Dai; Ying Liu; Maoji Cheng; Lijuan Chen
Journal:  Asian-Australas J Anim Sci       Date:  2017-06-27       Impact factor: 2.509

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.